Why wouldn't big pharma want to see this through an approved Phase 3 trial? I have a feeling that this will wake up at some point buy being bought or partnered. I see 2 dollars coming witha potential acquisition of MVAX.
Its better than Dendreon but I guess the market doesnt see it that way. Anyway. I am holding as I am a bagholder too, but I see potential.
Well here is my take. They are still listed on the pink sheets. They have patents that have to be worth a lot. If they get a partner for MVAX they will have the funding and the stock will be at or near 1 dollar on that news alone . Whether we get it or not is why we are at 6 cents.